By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

The Upper Austrian startup GENSPEED® Biotech develops a rapid test system for hospital bacteria and periodontal pathogens

GENSPEED®-Technology © GENSPEED® Biotech GmbH

Infections caused by antibiotic-resistant hospital bacteria that occur during hospital stays or infections with periodontal pathogens can result in serious consequences for affected patients. Both the detection of hospital bacteria in hospitals and the detection of periodontal pathogens in the dental field can take several days. The patient samples must either be examined through the use of lengthy in-house analyses or sent to external laboratories. With the rapid tests from GENSPEED® Biotech, hospital bacteria can be detected in the hospital laboratory in just 100 minutes, and periodontal pathogens can be detected in just 20 minutes directly at the dentist's practice. In both cases, rapid diagnosis allows for an immediate, targeted start of treatment. The GENSPEED immediate diagnosis system is a patented technology based on microfluid biochips, miniaturized optical detection and automation. In other words, the sample (e.g. from a nasal smear) is processed using standard methods and dripped into a so-called microfluid chip. No further intervention is required by the user, who can read the test result on the computer after a short time.

 

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Austria Oportunidades de negocio en el marco actual

    23. September 2020/ 10:00 - 11:15, Online Conference

  • China Global Investment Summit 2020

    24.09. - 25.09. 2020, Shenzen, China

Austria Map

Find the perfect location for your company

As a gaming machine and gaming software company, we particularly profit from the high level of education and innovative strength of Austria as a business location. We also value the strong loyalty and commitment of our local employees.

IGT Austria GmbH

igt
More testimonials

news from the business location Austria

Investment for augmented reality startup Amlogy

Augmented reality (AR) has always been a passion for Arkadi Jeghiazaryan.

Innovations from Vienna are a Growth Driver

Multinational companies invest € 2 billion in research in Austria every year. Many of the subsidiaries based in Austria carry out research and development activities in the Alpine Republic. Our company also does so. Ottobock has been operating in Austria for more than 50 years.

More news All blog posts